May 2018 $2 M No. 9 $2 to $10 million 6
Provista Diagnostics Inc.: Raise no. 9, May 2018 × Investors in this round 6 investors had bought by the notice of May 22, 2018: 6 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $5 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Gary Altman · Executive Officer, Director John G. Fermanis · Executive Officer Rao G. Mulpuri · Executive Officer Uriel E. Kusiatin · Executive Officer Cynthia E. Collins · Director Jack J. Levine · Director Jeffrey R. Gilman · Director John G. Zicarelli · Director John J. Macaskill · Director Robert J. Hariri · Director Thomas G. Mendell · Director Yoji G. Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Issuer is offering up to $5,000,000 in principal amount of convertible notes. This Form D is also intended to cover the underlying equity securities. A portion of the total amount sold was funded by cancellation of indebtedness and a note exchange.”Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed May 22, 2018. Read the notice at the SEC .
equity, debt SEC Jul 2017 $2 M No. 8 $2 to $10 million 28
Provista Diagnostics Inc.: Raise no. 8, Jul 2017 × Investors in this round 28 investors had bought by the notice of Sep 15, 2017: 28 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $2 M of $4 M offered; $2 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director Uriel E. Kusiatin · Executive Officer Anne E. Busquet · Director Jack E. Levine · Director Jeffrey E. Gilman · Director John E. Macaskill · Director John E. Zicarelli · Director Robert E. Hariri · Director Thomas E. Mendell · Director Yoji E. Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Issuer is offering up to $4,000,000 in principal amount of convertible promissory notes. This Form D is also intended to cover the underlying equity securities.”Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Sep 15, 2017. Read the notice at the SEC .
equity, debt SEC Oct 2016 $3 M No. 7 $2 to $10 million 5
Provista Diagnostics Inc.: Raise no. 7, Oct 2016 × Investors in this round 5 investors had bought by the notice of Oct 26, 2016: 5 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $3 M of $6 M offered; $3 M still to sell
Smallest investment taken no minimum stated
What was sold equity, debt Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director Uriel E. Kusiatin · Executive Officer Anne E. Busquet · Director Jack E. Levine · Director Jeffrey E. Gilman · Director John E. Macaskill · Director John E. Zicarelli · Director Robert E. Hariri · Director Thomas E. Mendell · Director Yoji E. Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the amounts: “The Issuer is offering up to $6,000,000 in principal amount of convertible promissory notes. This Form D is also intended to cover the underlying equity securities.”Signed by Uriel E. Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 26, 2016. Read the notice at the SEC .
equity, debt SEC Mar 2016 $5 M No. 6 $2 to $10 million 25
Provista Diagnostics Inc.: Raise no. 6, Mar 2016 × Investors in this round 25 investors had bought by the notice of Mar 18, 2016: 25 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $5 M of $5 M offered
Smallest investment taken $862
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director Uriel Kusiatin · Executive Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Thomas Mendell · Director Yoji Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Uriel E Kusiatin, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 18, 2016. Read the notice at the SEC .
equity SEC Jul 2015 $6 M No. 5 $2 to $10 million 27
Provista Diagnostics Inc.: Raise no. 5, Jul 2015 × Investors in this round 27 investors had bought by the notice of Aug 3, 2015: 27 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $261
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director John Fermanis · Executive Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Thomas Mendell · Director Yoji Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 3, 2015. Read the notice at the SEC .
equity SEC Feb 2015 $4 M No. 4 $2 to $10 million 24
Provista Diagnostics Inc.: Raise no. 4, Feb 2015 × Investors in this round 24 investors had bought by the notice of Mar 16, 2015: 24 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $4 M of $4 M offered
Smallest investment taken $20,162
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director John Fermanis · Executive Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Thomas Mendell · Director Yoji Nimura · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Mar 16, 2015. Read the notice at the SEC .
equity SEC Apr 2014 $6 M No. 3 $2 to $10 million 34
Provista Diagnostics Inc.: Raise no. 3, Apr 2014 × Investors in this round 34 investors had bought by the notice of Apr 17, 2014: 34 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $920
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director John Fermanis · Executive Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 17, 2014. Read the notice at the SEC .
equity, options SEC Apr 2013 $6 M No. 2 $2 to $10 million 35
Provista Diagnostics Inc.: Raise no. 2, Apr 2013 × Investors in this round 35 investors had bought by the notice of Apr 24, 2013: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $6 M of $6 M offered
Smallest investment taken $324
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director John Fermanis · Executive Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by John Fermanis, Chief Financial Officer. Source: SEC Form D, newest notice filed Apr 24, 2013. Read the notice at the SEC .
equity, options SEC Feb 2012 $7 M No. 1 $2 to $10 million 32
Provista Diagnostics Inc.: Raise no. 1, Feb 2012 × Investors in this round 32 investors had bought by the notice of Sep 21, 2012: 32 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $7 M of $7 M offered
Smallest investment taken $1,652
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them
Meant to last a year or less
Issuer's revenue Up to $1 million
Sales commissions none
Finders' fees none
Paid to its own people $52,000 (proceeds used for payments to executives, directors or promoters)
Estimates the notice marks payments to its own people as estimates
The company Corporation, incorporated in Delaware People named in the notice David Reese · Executive Officer, Director · President and Chief Executive Officer John Fermanis · Executive Officer · Chief Financial Officer Anne Busquet · Director Jack Levine · Director Jeffrey Gilman · Director John Macaskill · Director John Zicarelli · Director Robert Hariri · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Remarks in the notice On the use of proceeds: “Note repayment to an entity controlled by a director.”Signed by John N. Fermanis, Chief Financial Officer. Source: SEC Form D and 1 amendment, newest notice filed Sep 21, 2012. Read the notice at the SEC .
equity, options SEC